Cargando…
Does BCG provide long-term protection against SARS-CoV-2 infection? A case–control study in Quebec, Canada
BACKGROUND: Early in the coronavirus disease 2019 (COVID-19) pandemic, before severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines became available, it was hypothesized that BCG (Bacillus Calmette–Guérin), which stimulates innate immunity, could provide protection against SARS-CoV-2...
Autores principales: | Pépin, Jacques, Labbé, Annie-Claude, Carignan, Alex, Parent, Marie-Elise, Yu, Jennifer, Grenier, Cynthia, Beauchemin, Stéphanie, De Wals, Philippe, Valiquette, Louis, Rousseau, Marie-Claude |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354805/ https://www.ncbi.nlm.nih.gov/pubmed/34493410 http://dx.doi.org/10.1016/j.vaccine.2021.08.019 |
Ejemplares similares
-
Secular trends in incidence of invasive beta-hemolytic streptococci and efficacy of adjunctive therapy in Quebec, Canada, 1996-2016
por: Couture-Cossette, Antoine, et al.
Publicado: (2018) -
The Québec BCG Vaccination Registry (1956–1992): assessing data quality and linkage with administrative health databases
por: Rousseau, Marie-Claude, et al.
Publicado: (2014) -
PD45 - BCG vaccination and childhood asthma: preliminary results from the Québec Birth Cohort on Immunity and Health
por: Rousseau, Marie-Claude, et al.
Publicado: (2014) -
Changing Patterns of Disease Severity in Blastomyces dermatitidis Infection, Quebec, Canada
por: Carignan, Alex, et al.
Publicado: (2021) -
Possible Impact of Wide-scale Vaccination Against Serogroup B Neisseria Meningitidis on Gonorrhea Incidence Rates in One Region of Quebec, Canada
por: Longtin, Jean, et al.
Publicado: (2017)